Company Financials

VitaSpring Biomedical Co. Ltd Financials

United States dollar

business VitaSpring Biomedical Co. Ltd Company Profile

Main Stock Listing

OTC: VSBC

Market Capitalization $3.30 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 2607.56
Forward PE
Price to Sales TTM $663.65
Price to Book MRQ $2000.00
Enterprise to Revenue 4.21
Enterprise to EBITDA 17.60

Financial Reports as of Oct. 31, 2022

Financials

Fiscal Year Ends 2022-01-31
Most Recent Quarter 2022-10-31
Profit Margin 18.79%
Operating Margin 23.62%
Return on Assets TTM 40.98%
Return on Equity TTM 84.16%

Income Statement

Revenue TTM $4,979,000
Revenue per Share TTM $0.02
Quarterly Revenue Growth %
Gross Profit TTM $2,029,160
EBITDA $1,491,827
Net Income to Common TTM $935,613
Diluted EPS TTM $0.01
Quarterly Earnings Growth YoY -100.00%

Balance Sheet

Total Cash MRQ $24,050
Total Cash per Share MRQ $0.00
Total Debt MRQ $
Total Debt to Equity MRQ 19.61
Current Ratio MRQ 4.33
Book Value per Share MRQ $0.01

Cash Flow

Operating Cash Flow TTM $-240,006
Levered Free Cash Flow TTM $-481,095

VSBC Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 206,520,000
Float Shares None
Avg 10 Volume 20
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 58.77%
% Held by Institutions 0.00%

Stock Price Summary

Beta 1.13
Fifty Two Week Low $15.00
Fifty Two Week High $16.00
Fifty Two Week Change 0.00%
Day 50 MA $16.00
Day 200 MA $16.00

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2020-06-29